Quantinuum Inc. (NASDAQ:QNT – Get Free Report)’s stock price fell 7.2% during mid-day trading on Thursday. The company traded as low as $29.51 and last traded at $29.70. 1,549,987 shares were traded during trading, a decline of 34% from the average daily volume of 2,337,537 shares. The stock had previously closed at $31.99.
Analysts Set New Price Targets
Several brokerages recently commented on QNT. Needham & Company LLC cut their target price on Quantinuum from $100.00 to $60.00 and set a “buy” rating on the stock in a research report on Friday, November 6th. JPMorgan Chase & Co. lowered their price target on shares of Quantinuum from $97.00 to $80.00 and set an “overweight” rating for the company in a research report on Friday, November 6th. Bank of America decreased their price objective on Quantinuum from $85.00 to $50.00 and set a “buy” rating on the stock in a research note on Monday, November 9th. Rosenblatt Securities reaffirmed a “buy” rating and set a $155.00 target price on shares of Quantinuum in a research note on Thursday, October 22nd. Finally, Cantor Fitzgerald lowered their price objective on shares of Quantinuum from $90.00 to $55.00 and set an “overweight” rating for the company in a research note on Friday, November 6th. Fourteen analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Quantinuum has a consensus rating of “Moderate Buy” and a consensus target price of $80.21.
Check Out Our Latest Stock Report on Quantinuum
Quantinuum Price Performance
The stock’s 50 day simple moving average is $41.40. The stock has a market capitalization of $7.53 billion and a P/E ratio of -38.13.
Quantinuum (NASDAQ:QNT – Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported ($0.29) EPS for the quarter, beating analysts’ consensus estimates of ($0.99) by $0.70. The company had revenue of $9.05 million for the quarter. On average, analysts forecast that Quantinuum Inc. will post -3.70 earnings per share for the current fiscal year.
Institutional Trading of Quantinuum
A number of institutional investors have recently bought and sold shares of the business. Wellington Management Group LLP acquired a new stake in Quantinuum during the 2nd quarter worth approximately $92,418,000. Voya Investment Management LLC raised its holdings in shares of Quantinuum by 143.2% in the 3rd quarter. Voya Investment Management LLC now owns 1,681,316 shares of the company’s stock valued at $80,804,000 after acquiring an additional 989,879 shares in the last quarter. State Street Corp purchased a new stake in Quantinuum during the third quarter valued at about $18,491,000. HBK Investments L P purchased a new position in shares of Quantinuum during the second quarter valued at approximately $14,669,000. Finally, BlueCrest Capital Management Ltd bought a new stake in shares of Quantinuum during the second quarter valued at approximately $14,304,000.
About Quantinuum
Quantinuum develops quantum computers, software and cybersecurity products for businesses, researchers and government organizations. Its work includes trapped-ion quantum systems, tools for programming and managing quantum applications, and services focused on quantum chemistry and data security. The company was formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum, bringing together quantum hardware and software capabilities. Its offerings include the H-series quantum computers, the TKET software development kit and InQuanto, a platform for quantum chemistry research.
Featured Stories
- Five stocks we like better than Quantinuum
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.
